Lumactod, Rafica .
HRN: 24-77-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
METRONIDAZOLE 500MG (TAB)
04/02/2024
04/08/2024
ORAL
500 Mg
Q8
.
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes